1,014 filings
Page 12 of 51
SC 13G
Renaissance Technologies LLC
12 Feb 19
ARCA biopharma, Inc.
1:52pm
SC 13G/A
ABIO
ARCA biopharma Inc
12 Feb 19
ARCA biopharma, Inc.
9:04am
424B5
ABIO
ARCA biopharma Inc
25 Jan 19
Prospectus supplement for primary offering
4:46pm
8-K
ABIO
ARCA biopharma Inc
25 Jan 19
Entry into a Material Definitive Agreement
4:15pm
8-K
ABIO
ARCA biopharma Inc
20 Dec 18
ARCA Biopharma updates Special protocol assessment Request to FDA for gencaro phase 3 atrial fibrillation clinical trial
4:30pm
10-Q
2018 Q3
ABIO
ARCA biopharma Inc
Quarterly report
14 Nov 18
12:00am
8-K
ABIO
ARCA biopharma Inc
14 Nov 18
ARCA Biopharma announces THIRd quarter 2018 financial results AND Provides Corporate update
12:00am
8-K
ABIO
ARCA biopharma Inc
18 Oct 18
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
ABIO
ARCA biopharma Inc
9 Oct 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
DEF 14A
ABIO
ARCA biopharma Inc
Definitive proxy
20 Sep 18
4:06pm
8-K
ABIO
ARCA biopharma Inc
18 Sep 18
ARCA Biopharma Submits Special protocol assessment Request to FDA for gencaro phase 3 atrial fibrillation clinical trial
12:00am
PRE 14A
ABIO
ARCA biopharma Inc
Preliminary proxy
10 Sep 18
12:00am
8-K
ABIO
ARCA biopharma Inc
9 Aug 18
ARCA Biopharma announces second quarter 2018 financial results AND Provides Corporate update
12:00am
10-Q
2018 Q2
ABIO
ARCA biopharma Inc
Quarterly report
9 Aug 18
12:00am
8-K
ABIO
ARCA biopharma Inc
31 Jul 18
ARCA biopharma announces positive outcome of end-of-phase 2 meeting with fda on gencaro development for atrial fibrillatioN
4:16pm
8-K
ABIO
ARCA biopharma Inc
5 Jun 18
Submission of Matters to a Vote of Security Holders
5:10pm
8-K
ABIO
ARCA biopharma Inc
29 May 18
GENETIC-AF phase 2b clinical trial results presented in late
5:13pm
CT ORDER
ABIO
ARCA biopharma Inc
10 May 18
Confidential treatment order
12:00am
8-K
ABIO
ARCA biopharma Inc
8 May 18
ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate update
12:00am
10-Q
2018 Q1
ABIO
ARCA biopharma Inc
Quarterly report
8 May 18
12:00am